Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Lateral Flow Assay Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, ...

SHERIDAN, Wyo., Sept. 22, 2026 /PRNewswire/ -- The global lateral flow assay market is projected to grow from USD 11.04 billion in 2026 to USD 16.37 billion by 2031, registering a CAGR of 8.2% during ...

According to MarketsandMarkets™, the Lateral Flow Assays Market is projected to reach USD 13.52 billion by 2031 from USD 9.14 billion in 2026, at a CAGR of 8.1% during the forecast period.

A 2026 narrative review finds that rapid point-of-care technologies can detect pathogens and resistance markers closer to ...

An Iranian knowledge-based company has introduced a nanotechnology-based kit that uses lateral flow assay technology to ...

Intelligent Bio Solutions expects a sixth U.S. patent for its innovative non-invasive drug testing technology, enhancing market entry plans. Intelligent Bio Solutions Inc. (INBS), a medical technology ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

Lateral flow immunoassays (LFIAs) represent a class of paper-based diagnostic devices designed for rapid, on-site detection of specific biomarkers in complex samples. At their core, these assays rely ...